Sunrise, a healthtech company founded in 2015 in Belgium, has just closed a €3.25 million fundraising round. Led by Kurma Partners, this round of financing, in which the Vives-IUF fund linked to
Mont Saint-Guibert, Belgium – October 28, 2021 – Novadip Biosciences, a clinical stage company developing treatments to regenerate impaired tissue in patients with significant unmet medical needs,
Louvain-la-Neuve, 22 October 2021 – VOCSens raises €2.5 million in seed funding in order to industrialise its gas microsensors. The objective? The aim is to commercialise its micro gas sensors in the
European first in next-generation bacterium: pasteurized Akkermansia muciniphila from A-Mansia Biotech receives the green light from EFSA's scientific committee.
Excellent news for people at risk of
This new fundraising secures the financing of its Phase IIB study for HepaStem® in its flagship indication, Acute on Chronic Liver Failure (ACLF), a severe liver disease affecting more than 50000
LUXEMBOURG, June 29, 2021 – LMO, a company developing precision maneuvering technologies for in-space operations, with offices in Luxembourg and UK, secures funding from VIVES Inter-University Fund,
Mont-Saint-Guibert, June 15, 2021 – Novadip Biosciences (“Novadip”), a clinical stage company developing treatments to regenerate impaired tissues in patients with significant unmet medical needs,
March 31, 2021 - Louvain-la-Neuve, Belgium: Tessares - a technology company specializing in Hybrid Access software - has just concluded a new round of funding to fast forward an innovative software
LEUVEN, Belgium, March 22nd, 2021 — ViroVet NV, a leading Belgian biopharmaceutical company active in the development of innovative vaccines and antiviral drugs for livestock, is proud to announce
Vaccines alone are not enough to fight Covid-19. Experts pinpointed during several occasions on the importance of having antibody-based treatments available in combination with vaccines.
Authorization to start clinical trial in the US granted for rare paediatric bone disease
Mont-Saint-Guibert, Mar 4, 2021 (GlobeNewswire) – Novadip Biosciences (“Novadip”), a clinical stage company